Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Jounce Therapeutics, Inc.Listing unverified | Sell | $15.9M | SEC | ||
Voyager Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Voyager Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Global Blood Therapeutics, Inc.Listing unverified | Sell | $201.6K | SEC | ||
Global Blood Therapeutics, Inc.Listing unverified | Sell | $25.5M | SEC | ||
Global Blood Therapeutics, Inc.Listing unverified | Sell | $25.5M | SEC | ||
Global Blood Therapeutics, Inc.Listing unverified | Sell | $313.2K | SEC | ||
Global Blood Therapeutics, Inc.Listing unverified | Sell | $730.7K | SEC |